Benzinga | Sep 14, 2020 04:01PM EDT

Champions Oncology Q1 EPS $0.02, Inline, Sales $9.50M Beat $8.71M Estimate

Champions Oncology (NASDAQ:CSBR) reported quarterly earnings of $0.02 per share which met the analyst consensus estimate. This is a 140 percent increase over losses of $(0.05) per share from the same period last year. The company reported quarterly sales of $9.50 million which beat the analyst consensus estimate of $8.71 million by 9.07 percent. This is a 41.01 percent increase over sales of $6.74 million the same period last year.